Amwell expects Q4 2026 revenue of $48M-$50M and adjusted EBITDA from breakeven to $1M

Denali expects $30M-$32M Q4 AVLAYAH net product revenue as Sanfilippo BLA filing remains planned for 2027

Alamar signals $121M-$123M 2026 revenue while planning ARGO HT/DX FDA submission by end of next year

Astera Labs projects Q4 revenue of $730M-$750M driven by Scorpio X-Series expansion

There's a 99% Chance That Democrats Retake the House, and History Says This Shift Will Have a Huge Impact on Stocks